Navidea Biopharmaceuticals (FRA:NO1A) Other Long Term Assets : €0.01 Mil (As of Sep. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Navidea Biopharmaceuticals Other Long Term Assets?

Navidea Biopharmaceuticals's other long-term assets for the quarter that ended in Sep. 2023 was €0.01 Mil.

Navidea Biopharmaceuticals's quarterly other long-term assets declined from Mar. 2023 (€0.01 Mil) to Jun. 2023 (€0.01 Mil) but then increased from Jun. 2023 (€0.01 Mil) to Sep. 2023 (€0.01 Mil).

Navidea Biopharmaceuticals's annual other long-term assets increased from Dec. 2020 (€0.19 Mil) to Dec. 2021 (€0.20 Mil) but then declined from Dec. 2021 (€0.20 Mil) to Dec. 2022 (€0.01 Mil).

Navidea Biopharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Navidea Biopharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navidea Biopharmaceuticals Other Long Term Assets Chart

Navidea Biopharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long Term Assets

Get a 7-Day Free Trial

0.74

0.48

0.19

0.20

0.01

Navidea Biopharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Long Term Assets	Get a 7-Day Free Trial															0.03	0.01	0.01	0.01	0.01

Navidea Biopharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Navidea Biopharmaceuticals (FRA:NO1A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Navidea Biopharmaceuticals Inc (FRA:NO1A) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NAVB:USA

Address

4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552

Website

https://www.navidea.com

Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Navidea Biopharmaceuticals (FRA:NO1A) Headlines

No Headlines